Abstract Number: 2301 • 2015 ACR/ARHP Annual Meeting
Facing Fibromyalgia; How Patients Describe Their Symptoms Based on a Retrospective Evaluation of a Patient Survey and Vitality Assessment in Clinical Trials
Background/Purpose: Fibromyalgia (FM) is a common chronic widespread pain disorder with comorbid symptoms of fatigue, sleep disturbance, cognitive dysfunction and depression. It is believed to…Abstract Number: 2302 • 2015 ACR/ARHP Annual Meeting
The Impact of Prior Fibromyalgia Treatment on the Response to Pregabalin in Fibromyalgia Clinical Trials
Background/Purpose: Fibromyalgia (FM) is a chronic, widespread pain disorder for which Lyrica is an approved treatment. Antidepressants, gabapentin, muscle relaxants, and opioids are frequently used…Abstract Number: 2303 • 2015 ACR/ARHP Annual Meeting
Psychometrics of Online Administration of Fibromyalgia Impact Questionnaire – Revised
Background/Purpose: The Fibromyalgia Impact Questionnaire – Revised (FIQR) [1] has been in wide use since Bennett et al revised the original FIQ[2]. While the instrument…Abstract Number: 2304 • 2015 ACR/ARHP Annual Meeting
Clinical, Ultrasonographic and Neurophysiological Correlation of Patients with Carpal Tunnel Syndrome in Santo Domingo, Dominican Republic
Background/Purpose: Carpal Tunnel Syndrome (CTS) is produced by the entrapment of the median nerve (MN) in the carpal tunnel. It is characterized by pain and…Abstract Number: 2305 • 2015 ACR/ARHP Annual Meeting
Relationship Between Anxiety, Depression, Sleep, Fibromyalgia and BMI in Patients with Rheumatic Disease
Background/Purpose: Patients with rheumatic diseases often have comorbidities that complicate their psychological well-being and affect prognosis. In this study, we looked at 216 patients with…Abstract Number: 2306 • 2015 ACR/ARHP Annual Meeting
Prevalence of Fibromyalgia in Inflammatory Rheumatic Disease. Single-Center Cross-Sectional Study in 691 Patients
Background/Purpose: Fibromyalgia (FM) is a prevalent syndrome in patients with inflammatory rheumatic disease. The purpose of this study was to evaluate and compare the prevalence…Abstract Number: 2307 • 2015 ACR/ARHP Annual Meeting
Relationship of Sleep Quality and Fibromyalgia Outcomes in a Phase 2b Randomized, Double-Blind, Placebo-Controlled Study of Bedtime, Rapidly Absorbed, Sublingual Cyclobenzaprine (TNX-102 SL)
Background/Purpose: The importance of nonrestorative sleep in the pathophysiology of fibromyalgia (FM) suggests that treatments that improve sleep quality would address global symptoms. TNX-102 SL1a…Abstract Number: 2308 • 2015 ACR/ARHP Annual Meeting
Responder Compared to Mean Change Analyses in a Fibromyalgia Phase 2b Clinical Study of Bedtime Rapidly Absorbed Sublingual Cyclobenzaprine (TNX-102 SL)
Background/Purpose: Fibromyalgia (FM) is characterized by symptoms that include widespread pain and sleep disruption. Clinical studies that rely on patient self-reported outcome measures such as pain…Abstract Number: 2309 • 2015 ACR/ARHP Annual Meeting
Bedtime, Rapidly Absorbed Sublingual Cyclobenzaprine (TNX-102 SL) for the Treatment of Fibromyalgia: Results of a Phase 2b Randomized, Double-Blind, Placebo-Controlled Study
Background/Purpose: Fibromyalgia (FM) is characterized by chronic widespread pain and sleep disturbance. Treatments that improve sleep quality in FM patients may improve fibromyalgia by a…Abstract Number: 2310 • 2015 ACR/ARHP Annual Meeting
Evaluation of Fibromyalgia Syndrome in Patients Undergoing Peritoneal Dialysis
Background/Purpose: Fibromyalgia syndrome (FMS) is characterized by widespread pain, fatigue, memory problems. The syndrome is present in about %2-8 of general population. However, knowledge about this…Abstract Number: 2311 • 2015 ACR/ARHP Annual Meeting
Safety of Pregabalin for Treatment of Fibromyalgia Is Comparable Between Subjects with Moderate or Severe Baseline Widespread Pain
Background/Purpose: Pregabalin has demonstrated efficacy and safety for the treatment of pain associated with fibromyalgia (FM) and is approved by the US Food and Drug…Abstract Number: 2312 • 2015 ACR/ARHP Annual Meeting
Patient Preferences for Total Knee Replacement Surgery: Two Year Follow-up
Background/Purpose: Patients’ preferences for total knee replacement (TKR) may determine actual receipt of TKR and may also change over time. Yet, no study has longitudinally…Abstract Number: 2313 • 2015 ACR/ARHP Annual Meeting
Responder Rates and Numbers Needed to Treat Based on Clinically Meaningful Improvements in Patient Reported Outcomes (PROs) Including Health-Related Quality of Life (HRQoL) after Sarilumab Treatment during a Phase III Randomized Controlled Trial (RCT)
Background/Purpose: Sarilumab is a human monoclonal antibody (mAb) directed against the soluble IL-6 receptor (sIL-6R), administered subcutaneously (SC) every 2 weeks (q2w). In the phase…Abstract Number: 2314 • 2015 ACR/ARHP Annual Meeting
Minimal Important Difference in HAQ: A Validation from Health Economic Perspectives in Patient with Rheumatoid Arthritis Using Real-World Data
Background/Purpose: A change of 0.25 in HAQ score has been considered as clinically meaningful. This study is to evaluate the clinical meaningfulness of the HAQ…Abstract Number: 2315 • 2015 ACR/ARHP Annual Meeting
Six-Month Effects of a Multimedia Patient Education Tool in Patients with Rheumatoid Arthritis. a Randomized Controlled Trial
Background/Purpose: We conducted a multi-centered, open-label, parallel, randomized controlled trial to evaluate the efficacy of a multimedia-patient education tool (MM-PtET) for patients with rheumatoid arthritis…
ACR Meeting Abstracts